Allergan (AGN) Tops Q3 EPS by 30c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. WDAY
2. JNJ
3. AAPL
4. META
5. NRIX
6. SUNS
7. OIG
8. AMAT
9. SPY
10. SNDX

Go back to Allergan (AGN) Tops Q3 EPS by 30c

Allergan Reports Exceptional Third Quarter 2015 Continuing Operations Performance with 90% Increase in Net Revenue to $4.1 Billion and 65% Growth in Non-GAAP EPS to $3.48

November 4, 2015 7:30 AM EST

DUBLIN, Nov. 4, 2015 /PRNewswire/ -- Allergan plc (NYSE: AGN) reported continued exceptional performance with net revenue increasing 90 percent to $4.1 billion for the quarter ended September 30, 2015, compared to $2.2 billion in the third quarter 2014. On a non-GAAP basis, diluted earnings per share increased 65 percent to $3.48 for the third quarter 2015, compared to $2.11 in the third quarter 2014. GAAP loss from continuing operations per diluted share for the third quarter 2015 was $2.35, compared to GAAP loss from continuing operations per diluted share of $4.40 in the prior year period. GAAP results were impacted by amortization and acquisition-related expenses, including license agreements,... More